Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted.
about
Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome.Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.Hepatocyte gene therapy in a large animal: a neonatal bovine model of citrullinemiaNF-κB promotes leaky expression of adenovirus genes in a replication-incompetent adenovirus vector.Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboonsAdenovirus with DNA Packaging Gene Mutations Increased Virus Release.Adenoviral producer cellsA helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassette.Role for the adenovirus IVa2 protein in packaging of viral DNAProduction and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.Effect of the E4 region on the persistence of transgene expression from adenovirus vectors.Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivoPersistence of recombinant adenovirus in vivo is not dependent on vector DNA replication.Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication.
P2860
Q24813328-1A140964-49B2-4EFA-B3AA-248C3972A135Q33782356-926B939E-A8FD-4CAF-81A3-74C933479A6DQ35184207-42276A41-BE44-4656-A307-9C936AE6B281Q35874197-A0C2DD4F-48BF-4689-B775-16AEFA4183D6Q36455873-F2AA43BC-D65E-41BD-89AD-9823451AFB97Q36507633-0BB888DC-26AB-4D1C-A07B-560CF33D34B3Q36557727-E0466BCE-C943-4C13-A27C-2B40BEE83D17Q37539305-FF4219CE-B313-411C-9FE7-E599FB446B30Q37945217-55FE28C1-F6FE-49E2-995F-AF35B432474AQ39320579-5A37BED2-8141-4F91-8CEB-A7DE2AB767E8Q39604759-895DF576-69D0-4E8B-9B38-8475E05D02D0Q39642143-D20BCC00-DEBE-4258-9C48-5126038E5B5FQ39878778-6239ED8B-AAE0-4526-A9D7-82D13A4C5A38Q39880199-97778254-6CAA-4D8A-A63E-1894103E5D66Q39882372-9C77B4C3-6C59-42E1-9E69-7F0787A305CAQ40018751-6B488B2C-7F9F-4E75-A6FB-913DB089F159
P2860
Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Development of a complementing ...... ctors with E1 and E2a deleted.
@en
Development of a complementing ...... ctors with E1 and E2a deleted.
@nl
type
label
Development of a complementing ...... ctors with E1 and E2a deleted.
@en
Development of a complementing ...... ctors with E1 and E2a deleted.
@nl
prefLabel
Development of a complementing ...... ctors with E1 and E2a deleted.
@en
Development of a complementing ...... ctors with E1 and E2a deleted.
@nl
P2093
P2860
P1433
P1476
Development of a complementing ...... ctors with E1 and E2a deleted.
@en
P2093
P2860
P304
P407
P50
P577
1996-10-01T00:00:00Z